CLRB - 1.71 Pre-market now at 1.80/1.85 Cellectar Biosciences Receives Additional Japanese Patent for CLR 131 and CLR 125 for the Treatment of Various Solid Tumors http://stockcharts.com/c-sc/sc?s=CLRB&p=D&b=5&g=0&i=t84257585270&r=1508243739738 http://stockcharts.com/c-sc/sc?s=CLRB&p=W&b=5&g=0&i=t06907004472&r=1508243761982